{"id":"https://openalex.org/W55079782","doi":null,"title":"Clinical trials of single-agent trastuzumab (Herceptin).","display_name":"Clinical trials of single-agent trastuzumab (Herceptin).","publication_year":2000,"publication_date":"2000-10-01","ids":{"openalex":"https://openalex.org/W55079782","mag":"55079782","pmid":"https://pubmed.ncbi.nlm.nih.gov/11049053"},"language":"en","primary_location":{"id":"pmid:11049053","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11049053","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"J Baselga","raw_affiliation_strings":["Medical Oncology Service, Hospital General Universitari Vall D'Hebron, and the Universidad Autonoma de Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Service, Hospital General Universitari Vall D'Hebron, and the Universidad Autonoma de Barcelona, Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5004300577"],"corresponding_institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"],"apc_list":null,"apc_paid":null,"fwci":1.733,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.83674218,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"27","issue":"5 Suppl 9","first_page":"20","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":1.0},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.7009999752044678},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.7979999780654907},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8830000162124634},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.734000027179718},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8460000157356262},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.5299999713897705},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6650000214576721},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7919999957084656},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9564923048019409},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9324080944061279},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6669966578483582},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6303078532218933},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6087232828140259},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.59186190366745},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5363686084747314},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.516423761844635},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4934345781803131},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.444724440574646},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3946579098701477},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11049053","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11049053","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},{"id":"mag:55079782","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11049053","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W203485479","https://openalex.org/W2108795463","https://openalex.org/W2285386092","https://openalex.org/W1998297552","https://openalex.org/W4381568581","https://openalex.org/W2087238575","https://openalex.org/W148386962","https://openalex.org/W2122838632","https://openalex.org/W2170343440","https://openalex.org/W4239989216"],"abstract_inverted_index":{"The":[0,197,225,263],"HER2":[1,21,67],"gene":[2],"(also":[3],"known":[4],"as":[5,8,258],"neu":[6],"and":[7,41,90,261,273],"c-erb-B2)":[9],"encodes":[10],"a":[11,33,44,60,133,139,165,193],"185-kd":[12],"transmembrane":[13],"glycoprotein":[14],"receptor":[15],"with":[16,49,116,248,277],"intrinsic":[17],"tyrosine":[18],"kinase":[19],"activity.":[20],"is":[22,245,271],"overexpressed":[23],"in":[24,35,47,75,106,114,132,187,202,238,275],"25%":[25],"to":[26,72,87,91,209,222],"30%":[27],"of":[28,38,99,143,167,200,242,255],"human":[29],"breast":[30,39,119,280],"cancers,":[31],"plays":[32],"role":[34],"the":[36,66,107,122,127,171,249],"pathogenesis":[37],"cancer,":[40],"predicts":[42],"for":[43,159],"worse":[45],"prognosis":[46],"patients":[48,115,149,190,276],"metastatic":[50,118,160,278],"disease.":[51],"Trastuzumab":[52,244],"(Herceptin;":[53],"Genentech,":[54],"Inc,":[55],"So.":[56],"San":[57],"Francisco,":[58],"CA),":[59],"humanized":[61],"monoclonal":[62],"antibody":[63],"that":[64,269],"targets":[65],"oncogene":[68],"receptor,":[69],"was":[70,85,103,130,181],"shown":[71,192,221],"be":[73,88,223],"active":[74,272],"preclinical":[76],"models.":[77],"In":[78,121,138,212],"initial":[79,123],"phase":[80,96,124,215],"I":[81],"clinical":[82],"trials,":[83],"trastuzumab":[84,218,270],"found":[86],"safe":[89,274],"exhibit":[92],"dose-dependent":[93],"pharmacokinetics.":[94],"Three":[95],"II":[97,125,216],"studies":[98,267],"single-agent":[100,144],"trastuzumab,":[101,145],"which":[102,236],"administered":[104],"weekly":[105],"outpatient":[108],"setting,":[109],"have":[110],"now":[111],"been":[112,220,232],"conducted":[113],"HER2-overexpressing":[117,279],"cancer.":[120,281],"study,":[126],"response":[128,172,178,195,201],"rate":[129,173],"11%":[131],"heavily":[134],"pretreated":[135],"patient":[136],"population.":[137],"pivotal":[140],"follow-up":[141],"study":[142,186],"more":[146,184],"than":[147,240],"200":[148],"who":[150],"had":[151],"received":[152],"at":[153],"least":[154],"one":[155],"prior":[156],"chemotherapeutic":[157],"regimen":[158],"disease":[161],"were":[162],"entered.":[163],"Despite":[164],"number":[166],"unfavorable":[168],"baseline":[169],"characteristics,":[170],"reported":[174],"by":[175],"an":[176],"independent":[177],"evaluation":[179],"committee":[180],"15%.":[182],"A":[183],"recent":[185],"previously":[188],"untreated":[189],"has":[191,205,219,231],"23%":[194],"rate.":[196],"median":[198],"duration":[199],"these":[203,213,266],"trials":[204],"ranged":[206],"from":[207,265],"6.6":[208],"9.1":[210],"months.":[211],"three":[214],"studies,":[217],"safe.":[224],"most":[226],"clinically":[227],"significant":[228],"adverse":[229],"event":[230],"cardiac":[233],"dysfunction":[234],"syndrome,":[235],"occurred":[237],"less":[239],"5%":[241],"patients.":[243],"not":[246],"associated":[247],"other":[250],"commonly":[251],"observed":[252],"side":[253],"effects":[254],"chemotherapy,":[256],"such":[257],"alopecia,":[259],"mucositis,":[260],"neutropenia.":[262],"results":[264],"demonstrate":[268]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}